Tailored Diarylalkane Solutions for Specialized Skin Care Needs

Publication ID: 24-11857657_0004_PTD
Published: October 28, 2025
Category:Specialized Variations & Niche Solutions

Legal Citation

pr1or.art Inc., “Tailored Diarylalkane Solutions for Specialized Skin Care Needs,” Published Technical Disclosure No. 24-11857657_0004_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857657_0004_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,657.

Summary of the Inventive Concept

This inventive concept adapts diarylalkane-based compositions for specific, niche skin care applications, including high-altitude environments, sensitive skin, albinism, vitiligo, and dark skin tones. These specialized solutions address unmet needs in these markets, providing targeted and effective treatments for skin pigmentation, melanin synthesis, and skin damage.

Background and Problem Solved

The original patent disclosed diarylalkane-based compositions for treating skin pigmentation due to inflammatory conditions. However, these compositions may not be suitable for specific, niche markets with unique operational environments or skin characteristics. The present inventive concept addresses these limitations by developing tailored solutions that cater to these special needs, ensuring effective and safe treatments.

Detailed Description of the Inventive Concept

The new inventive concept comprises five specialized variations of diarylalkane-based compositions, each designed to address a specific skin care need. The first variation is a system for treating skin pigmentation in high-altitude environments, where low oxygen levels can affect composition stability. The second variation is a method for inhibiting melanin synthesis in individuals with sensitive skin, using a transdermal patch formulation to minimize skin irritation. The third variation is a composition for treating skin discoloration in individuals with albinism, formulated to enhance skin penetration in compromised skin barriers. The fourth variation is a system for preventing skin damage from UV radiation in individuals with vitiligo, providing enhanced photoprotection. The fifth variation is a method for treating skin hyperpigmentation in individuals with dark skin tones, using a topical formulation that minimizes skin whitening and promotes even skin tone.

Novelty and Inventive Step

The new claims introduce novel and non-obvious adaptations of diarylalkane-based compositions for specific, niche skin care applications. These adaptations involve unique formulations, delivery systems, and operational environments that depart from the original patent's disclosures. The inventive step lies in recognizing the need for tailored solutions in these specialized markets and developing targeted compositions that address these needs.

Alternative Embodiments and Variations

Other possible embodiments of the inventive concept could include diarylalkane-based compositions for treating skin conditions in extreme weather environments, such as desert or tropical climates. Additionally, the inventive concept could be adapted for use in cosmetic products, such as sunscreens or moisturizers, to provide enhanced skin protection and care.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in the skincare industry, particularly in niche markets with unmet needs. Target industries include pharmaceutical companies, cosmetic manufacturers, and dermatology clinics. The specialized solutions offered by the inventive concept could provide a competitive edge in these markets, addressing specific skin care needs and improving treatment outcomes.

CPC Classifications

SectionClassGroup
A A61 A61K8/347
A A61 A61K8/31
A A61 A61K8/4973
A A61 A61K8/9789
A A61 A61K8/9794
A A61 A61K31/015
A A61 A61K31/05
A A61 A61K31/085
A A61 A61K31/09
A A61 A61K31/357
A A61 A61K31/40
A A61 A61K31/704
A A61 A61Q19/02
C C07 C07C39/15
C C07 C07C39/367
C C07 C07C41/26
C C07 C07C41/32
C C07 C07C43/23
C C07 C07C45/673
C C07 C07C49/835
C C07 C07C215/74
C C07 C07D321/12
A A61 A61K2800/782
Y Y02 Y02A50/30

Original Patent Information

Patent NumberUS 11,857,657
TitleDiarylalkanes as potent inhibitors of binuclear enzymes
Assignee(s)Unigen, Inc.